1 of 1
Story summary
- Artificial intelligence (AI) accelerates cancer drug discovery by integrating large datasets to identify targets.
- AI tools optimize clinical trials, improving patient recruitment and predicting trial outcomes.
- Experts at the Patient-Centered Oncology Care conference discussed AI's role in precision oncology, emphasizing transparency and trust.
- Regulatory frameworks are evolving to address AI safety, partnerships among academia, industry, and regulators.
